Investments
Jun. 17, 2003
San Diego Stands Out in Biotech Activity
San Diego continues to show its strength as a center of biotech activity. Santarus Inc. has raised $51 million in a fourth round of financing, which the San Diego drug company plans to use to further develop its products for gastrointestinal diseases.
Santarus Inc. has raised $51 million in a fourth round of financing, which the San Diego drug company plans to use to further develop its products for gastrointestinal diseases.
Its initial ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In